Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway.

Summary: Breast cancer is a very common and serious disease for women. Scientists tested a cancer-fighting drug called Everolimus to see how well it works. They found that Everolimus stops breast cancer cells from growing and spreading. It works by blocking a specific communication path inside the cells, which tells the cancer cells to die off instead of multiplying. The drug was highly successful at shrinking tumors in both lab dishes and in mice. This shows that Everolimus is a very promising treatment for fighting breast cancer.